The timing with which patients with newly diagnosed multiple myeloma began treatment with oral antimyeloma medications varied greatly by age and race, according to retrospective study results.
Black individuals and older adults appeared significantly less likely to fill prescriptions for oral antimyeloma medications within 30 days of diagnosis.
“There has been considerable improvement in the OS of patients with multiple myeloma over the past 2 decades thanks to major advances in treatment,” Hamlet Gasoyan, PhD, assistant professor of medicine at Cleveland Clinic Lerner College of
